Tumour necrosis factor receptor-associated periodic syndrome

DBCOND0008484Congenital, Hereditary, and Neonatal Diseases and Abnormalities Disease and Non-Disease Concepts, Unclassified

Tumour necrosis factor receptor-associated periodic syndrome is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: TNF-receptor Associated Periodic Syndromes (TRAPS)
Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Disease and Non-Disease Concepts, Unclassified
Immune System Diseases
Signs, Symptoms, and General Pathologies
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Canakinumab

Resolves to

Vocabularies

SNOMED CT403833009MedDRA10067774UMLSC1275126

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

2Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Tumour necrosis factor receptor-associated periodic syndrome share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account